PRESS RELEASE published on 08/06/2024 at 21:07, 1 year 9 months ago Evotec provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting moderate revenue growth, reduced R&D expenditures, and adjusted EBITDA; aims for sustainable profitable growth amid market challenges Adjusted EBITDA Revenue Growth Evotec SE Guidance Update R&D Expenditures
PRESS RELEASE published on 08/06/2024 at 21:04, 1 year 9 months ago EQS-Adhoc: Evotec SE provides guidance update Evotec SE refines guidance for fiscal year 2024, expecting revenue and EBITDA adjustments due to slower sales conversion and margin pressures, focusing on sustainable growth EBITDA Revenue Evotec SE Sustainable Growth Guidance Update
BRIEF published on 07/10/2024 at 07:35, 1 year 10 months ago Evotec and Pfizer Collaborate to Advance Drug Discovery in France Drug Discovery Metabolic Diseases Evotec Pfizer Infectious Diseases
PRESS RELEASE published on 07/10/2024 at 07:30, 1 year 10 months ago Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE collaborates with Pfizer to focus on early discovery research for metabolic and infectious diseases in France. The multi-year agreement includes research support and potential milestones Drug Discovery Evotec SE France Pfizer Metabolic And Infectious Diseases
BRIEF published on 07/08/2024 at 14:05, 1 year 10 months ago Just – Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz Partnership Biosimilars Evotec Sandoz Biologics
PRESS RELEASE published on 07/08/2024 at 14:00, 1 year 10 months ago Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE's biologics segment, Just - Evotec Biologics, expands partnership for biosimilars with Sandoz, securing long-term commercial supply. Collaboration aims for cost-efficient development Evotec SE Biosimilars Just - Evotec Biologics Sandoz Commercial Supply
BRIEF published on 06/25/2024 at 07:35, 1 year 11 months ago Just-Evotec Biologics Selected by U.S. DOD for Manufacturing Optimization Evotec SE Biologics Manufacturing U.S. Department Of Defense Monoclonal Antibodies Medical Countermeasures
PRESS RELEASE published on 06/25/2024 at 07:30, 1 year 11 months ago Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program Just \/ Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program. Evotec SE subsidiary chosen for $39m accelerated mAb development project Evotec SE Just - Evotec Biologics U.S. Department Of Defense Manufacturing Optimization Program MAb Development
BRIEF published on 06/12/2024 at 07:35, 1 year 11 months ago Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Collaboration Neuroscience Evotec Neurodegenerative Diseases Bristol Myers Squibb
PRESS RELEASE published on 06/12/2024 at 07:30, 1 year 11 months ago Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb Evotec SE makes progress in neuroscience collaboration with Bristol Myers Squibb, receiving a US$20m research payment. The partnership focuses on developing treatments for neurodegenerative diseases Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Neuroscience Collaboration Research Payment
Published on 06/02/2026 at 19:40, 56 minutes ago Taranis Outlines Four High-Priority Targets Around Thor and Thirty Prospects and Old Mines Located within 6,470 Ha Property
Published on 06/02/2026 at 16:15, 4 hours 21 minutes ago Vulcan Minerals Inc. - Drilling to Resume at Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 06/02/2026 at 15:05, 5 hours 31 minutes ago Apex Announces Closing of Brokered LIFE Offering for Gross Proceeds of $15,000,500
Published on 06/02/2026 at 15:04, 5 hours 32 minutes ago LQR House Inc. Closes Additional 30% Interest in Fusion Five Continents Securities, Crossing Majority Ownership of an AI-Powered Cross-Border Brokerage Built on USDT Settlement Infrastructure
Published on 06/02/2026 at 19:50, 45 minutes ago Recorded Future Announces Strategic Partnership with Wipro to Deliver AI-Powered Threat Intelligence at Global Enterprise Scale
Published on 06/02/2026 at 19:28, 1 hour 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2026 at 17:45, 2 hours 51 minutes ago LightOn launches a sovereign SaaS offering to simplify enterprise integration of document AI.
Published on 06/02/2026 at 18:03, 2 hours 32 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 2 hours 54 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 2 hours 56 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 12 hours 36 minutes ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 13 hours 6 minutes ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
